CXCL8 and systemic lupus erythematosus: Given that IL-8 is a stimulant for neutrophil activation, which plays a significant role in the pathogenesis of SLE (Kaplan, 2011), targeting IL-8 secretion or signaling could constitute a therapeutic strategy for SLE.